Statin Therapy and Risks for Death and Hospitalization in Chronic Heart Failure
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
CONTEXT: Whether statin therapy has beneficial effects on clinical outcomes in patients with heart failure is unclear. OBJECTIVE: To evaluate the association between initiation of statin therapy and risks for death and hospitalization among adults with chronic heart failure. DESIGN, SETTING, AND PATIENTS: Propensity-adjusted cohort study of adults diagnosed with heart failure who were eligible for lipid-lowering therapy but had no previous known statin use, within an integrated health care delivery system in northern California between January 1, 1996, and December 31, 2004. Statin use was estimated from filled outpatient prescriptions in pharmacy databases. MAIN OUTCOME MEASURES: All-cause death and hospitalization for heart failure during a median of 2.4 years of follow-up. We examined the independent relationships between statin therapy and risks for adverse events overall and stratified by the presence or absence of coronary heart disease after multivariable adjustment for potential confounders. RESULTS: Among 24,598 adults diagnosed with heart failure who had no prior statin use, those initiating statin therapy (n = 12,648; 51.4%) were more likely to be younger, male, and have known cardiovascular disease, diabetes, and hypertension. There were 8235 patients who died. Using an intent-to-treat approach, incident statin use was associated with lower risks of death (age- and sex-adjusted rate of 14.5 per 100 person-years with statin therapy vs 25.3 per 100 person-years without statin therapy; adjusted hazard ratio, 0.76 [95% confidence interval, 0.72-0.80]) and hospitalization for heart failure (age- and sex-adjusted rate of 21.9 per 100 person-years with statin therapy vs 31.1 per 100 person-years without statin therapy; adjusted hazard ratio, 0.79 [95% confidence interval, 0.74-0.85]) even after adjustment for the propensity to take statins, cholesterol level, use of other cardiovascular medications, and other potential confounders. Incident statin use was associated with lower adjusted risks of adverse outcomes in patients with or without known coronary heart disease. CONCLUSION: Among adults diagnosed with heart failure who had no prior statin use, incident statin use was independently associated with lower risks of death and hospitalization among patients with or without coronary heart disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The central role of the propensity score in observational studies for causal effects
ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Self-citationModeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,154
Writing Group Members, Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., Zheng, Z.-J., Flegal, K., O’Donnell, C., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.171600 · Cited by 3,451
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Segmented regression analysis of interrupted time series studies in medication use research
Wagner, A. K., Soumerai, S. B., Zhang, F., & Ross-Degnan, D. (2002) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2002.00430.x · Cited by 3,279
The Central Role of the Propensity Score in Observational Studies for Causal Effects
Rosenbaum, P. R., & Rubin, D. B. (1983) · Biometrika · doi:10.2307/2335942 · Cited by 3,261
(2006) · PsycEXTRA Dataset · doi:10.1037/e545592006-001 · Cited by 2,958
Estimating Causal Effects from Large Data Sets Using Propensity Scores
Rubin, D. B. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-8_part_2-199710151-00064 · Cited by 2,877
(2000) · Journal of the American Society of Nephrology · Cited by 1,718
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
Trends in Heart Failure Incidence and Survival in a Community-Based Population
Roger, V. L. (2004) · JAMA · doi:10.1001/jama.292.3.344 · Cited by 1,600
Effect of Statins on Risk of Coronary Disease: A Meta-analysis of Randomized Controlled Trials
LaRosa, J. C., He, J., & Vupputuri, S. (1999) · JAMA · doi:10.1001/jama.282.24.2340 · Cited by 1,246
Rule, A. D., Larson, T. S., Bergstralh, E. J., Slezak, J. M., Jacobsen, S. J., & Cosio, F. G. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-12-200412210-00009 · Cited by 1,066
Safety of Statins: Focus on Clinical Pharmacokinetics and Drug Interactions
Bellosta, S., Paoletti, R., & Corsini, A. (2004) · Circulation · doi:10.1161/01.cir.0000131519.15067.1f · Cited by 578 · cited 1×
“Statins may diminish the ability of lipoproteins to bind endotoxins leading to stimulation of proinflammatory cytokines(13); reduce levels of coenzyme Q10(14) and selenoproteins,(15) which could adversely affect cardiac muscle and function; and have deleterious interactions with medications commonly used for heart fai…”
BackgroundThe endotoxin-lipoprotein hypothesis
Rauchhaus, M., Coats, A. J., & Anker, S. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02690-8 · Cited by 533
Go, A. S., Yang, J., Ackerson, L. M., Lepper, K., Robbins, S., Massie, B. M., & Shlipak, M. G. (2006) · Circulation · doi:10.1161/circulationaha.105.577577 · Cited by 515
Self-citationThe relationship between cholesterol and survival in patients with chronic heart failure
Rauchhaus, M., Clark, A. L., Doehner, W., Davos, C., Bolger, A., Sharma, R., Coats, A. J. S., & Anker, S. D. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.07.016 · Cited by 444
Excess Costs of Medical Care for Patients With Diabetes in a Managed Care Population
Selby, J. V., Ray, G. T., Zhang, D., & Colby, C. J. (1997) · Diabetes Care · doi:10.2337/diacare.20.9.1396 · Cited by 344
Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure
Horwich, T. B., MacLellan, W. R., & Fonarow, G. C. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.07.049 · Cited by 341
Sola, S., Mir, M. Q. S., Khan, B. V., Lerakis, S., & Tandon, N. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.088 · Cited by 324
Horwich, T. B., Hamilton, M. A., MacLellan, W. R., & Fonarow, G. C. (2002) · Journal of Cardiac Failure · doi:10.1054/jcaf.2002.126519a · Cited by 279
Effectiveness of Statin Therapy in Adults With Coronary Heart Disease
Wilt, T. J., Bloomfield, H. E., MacDonald, R., Nelson, D., Rutks, I., Ho, M., Larsen, G., McCall, A., Pineros, S., & Sales, A. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.13.1427 · Cited by 275
Pignone, M. (2000) · BMJ · doi:10.1136/bmj.321.7267.983 · Cited by 259
Tavazzi, L., Tognoni, G., Franzosi, M. G., Latini, R., Maggioni, A. P., Marchioli, R., Nicolosi, G. L., & Porcu, M. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.03.001 · Cited by 240
Selenoprotein synthesis and side-effects of statins
Moosmann, B., & Behl, C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15739-5 · Cited by 220
Use of Commercial Record Linkage Software and Vital Statistics to Identify Patient Deaths
Newman, T. B., & Brown, A. N. (1997) · Journal of the American Medical Informatics Association · doi:10.1136/jamia.1997.0040233 · Cited by 200
The Natural History of Congestive Heart Failure
Littmann, D. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852609 · Cited by 190
Statin therapy is associated with lower mortality among patients with severe heart failure
Mozaffarian, D., Nye, R., & Levy, W. C. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.01.039 · Cited by 179
Rundek, T., Naini, A., Sacco, R., Coates, K., & DiMauro, S. (2004) · Archives of Neurology · doi:10.1001/archneur.61.6.889 · Cited by 161
Henke, P. K., Blackburn, S. A., Proctor, M., Stevens, J., Mukherjee, D., Rajagopalin, S., Upchurch, G. R., Stanley, J. C., & Eagle, K. A. (2004) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2003.08.030 · Cited by 159
The California Automated Mortality Linkage System (CAMLIS).
Arellano, M. G., Petersen, G. R., Petitti, D. B., & Smith, R. E. (1984) · American Journal of Public Health · doi:10.2105/ajph.74.12.1324 · Cited by 156
Kjekshus, J., Dunselman, P., Blideskog, M., Eskilson, C., Hjalmarson, Å., McMurray, J. V., Waagstein, F., Wedel, H., Wessman, P., & Wikstrand, J. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.09.005 · Cited by 153
Urbich, C., & Dimmeler, S. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00261.x · Cited by 153
Effect of Statins on Risk of Coronary Disease: A Meta-analysis of Randomized Controlled Trials
LAROSA, J. C., HE, J., & VUPPUTURI, S. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200012000-00024 · Cited by 153
Statin Use and Survival Outcomes in Elderly Patients With Heart Failure
Ray, J. G., Gong, Y., Sykora, K., & Tu, J. V. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.1.62 · Cited by 121
Vrtovec, B., Okrajšek, R., Goličnik, A., Ferjan, M., Starc, V., & Radovančević, B. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.06.439 · Cited by 94
Strey, C. H., Young, J. M., Molyneux, S. L., George, P. M., Florkowski, C. M., Scott, R. S., & FRAMPTON, C. M. A. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.10.009 · Cited by 93
Tousoulis, D., Antoniades, C. A., Bosinakou, E., Kotsopoulou, M., Pitsavos, C. E., Vlachopoulos, C. V., Panagiotakos, D. B., & Stefanadis, C. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.08.037 · Cited by 88
Bleske, B. E., Nicklas, J. M., Bard, R. L., Brook, R. D., Gurbel, P. A., Bliden, K. P., Rajagopalan, S., & Pitt, B. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.087 · Cited by 86
Cost of Care for Patients in Cancer Clinical Trials
FIREMAN, B. H., Fehrenbacher, L., Gruskin, E. P., & Ray, G. T. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.2.136 · Cited by 85
The Effects of Atorvastatin (10 mg) on Systemic Inflammation in Heart Failure
Mozaffarian, D., Minami, E., Letterer, R. A., Lawler, R. L., McDonald, G. B., & Levy, W. C. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.07.092 · Cited by 73
Gender and risk of adverse outcomes in heart failure
Lee, W. Y., Capra, A. M., Jensvold, N. G., Gurwitz, J. H., & Go, A. S. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.07.081 · Cited by 66
Self-citationStatins in the Treatment of Chronic Heart Failure: A Systematic Review
van der Harst, P., Voors, A. A., van Gilst, W. H., Böhm, M., & van Veldhuisen, D. J. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030333 · Cited by 55
Heart failure and statins—Why do we need a clinical trial?
Böhm, M., Hjalmarson, Å. C., KJEKSHUS, J. K., Laufs, U., McMurray, J. J. V., & van Veldhuisen, D. J. (2005) · Zeitschrift für Kardiologie · doi:10.1007/s00392-005-0210-9 · Cited by 25
Statin therapy is associated with improved survival in ischemic and nonischemic heart failure
Horwich, T. B., Hamilton, M. A., MacLeilan, R., Patel, J. K., Lesniewski, M., & Fonarow, G. C. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)81801-6 · Cited by 12
Cited by
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8776 · Cited by 2,106
Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction
Yeh, R. W., Sidney, S., Chandra, M., Sorel, M., Selby, J. V., & Go, A. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908610 · Cited by 1,735
Self-citationRosuvastatin in older patients with systolic heart failure
Kjekshus, J., Apetrei, E., Barrios, V., Böhm, M., Cleland, J. G. F., Cornel, J. H., Dunselman, P., Fonseca, C., Goudev, A., Grande, P., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706201 · Cited by 1,487
Metadata
- Authors
- Go, A. S., Lee, W. Y., Yang, J., Lo, J. C., & Gurwitz, J. H.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2006-11-01
- Volume
- 296
- Issue
- 17
- Pages
- 2105
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1974451585
- Cited by
- 291
- References
- 51
- FWCI
- 15.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.